Diabetes Types 1 and 2: Management Strengths and Complication Risks
Type 1 Diabetes (T1D)
- Pathophysiology: Autoimmune β-cell destruction → absolute insulin deficiency
- Onset: Typically childhood/adolescence; can occur at any age
- Management: Insulin (basal-bolus MDI or pump), CGM, carb counting
- Strengths: Predictable insulin requirement; technology (AID systems) enables near-physiologic control
Type 2 Diabetes (T2D)
- Pathophysiology: Insulin resistance + progressive β-cell dysfunction
- Onset: Typically adult; rising in youth with obesity
- Management: Lifestyle → metformin → GLP-1 RA/SGLT2i → insulin
- Strengths: Often preventable/delayable; multiple drug classes with CV/renal benefits
Shared Complication Risks (If Uncontrolled)
- Microvascular: Retinopathy, nephropathy, neuropathy
- Macrovascular: CAD, stroke, PAD (2–4× risk)
- Infections, poor wound healing
- Hypoglycemia (treatment-induced)
- Diabetic ketoacidosis (T1D) / HHS (T2D)
Keys to Long-Term Health
- A1c <7% individualized
- BP <130/80, LDL <70 (or <55 if ASCVD)
- SGLT2i/GLP-1 RA for cardio-renal protection
- Annual eye, foot, kidney screening
- Diabetes self-management education (DSMES)
Diabetes - Related Articles